Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Merck & Co, Inc.

Community Practice Connections™: Evolutions in the Treatment and Management of Advanced Cervical Cancer: Leveraging the Immunosuppressive Microenvironment, Addressing Ongoing Clinical Needs


Release Date: June 30, 2019
Expiration Date: June 30, 2020
Media: Internet - based

Activity Overview

Although cervical cancer is highly treatable and associated with high rates of positive clinical outcomes when detected early enough, many cases are not detected until they have reached an advanced stage. The management of patients with advanced/metastatic disease remains an important clinical challenge. Pursuit of treatment options that may help to improve clinical efficacy and limit treatment-associated adverse events is an active area of investigation, with several options showing promise in recent studies. The understanding of the mechanisms underlying the development of cervical cancer has helped to inform new approaches to its treatment, which may improve outcomes for your patients. Keeping up with these advancements can be a challenging goal for busy clinicians, as can development of a thorough understanding of potential applications of new data from trials evaluating therapeutic approaches for advanced cervical cancer. Through a series of cases, descriptive text, interview video clips, and self-assessment questions, the expert faculty of this online activity address multiple clinical challenges and key topics pertaining to the management of cervical cancer in the era of immunotherapy.

Benefits of Participating

  • Gain insights into recent developments in the management of advanced cervical cancers
  • Increase your understanding of the clinical relevance of tumor characterization and the tumor microenvironment
  • Improve your awareness of ongoing clinical trials that may change the treatment paradigm for your patients with these cancers

CME Activity Table of Contents

  • Pretest
  • Module 1: Case Study of a 44-Year-Old Woman With Squamous Cell Cervical Cancer
    Bradley J. Monk, MD, FACS, FACOG
  • Module 2: Current Advanced Cervical Cancer Landscape: Progress and Challenges
    Robert L. Coleman, MD, FACOG, FACS, and Bradley J. Monk, MD, FACS, FACOG
  • Module 3: Current and Emerging Uses of Immunotherapeutics for Cervical Cancer: Expert Insights on Key Data Sets
    Leslie M. Randall, MD, MAS, and Bradley J. Monk, MD, FACS, FACOG
  • Posttest and Evaluation

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Merck & Co, Inc.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME certificate upon completion of these steps.


Target Audience

This educational program is directed toward medical oncologists, gynecologic oncologists, pathologists, radiation oncologists, and surgical oncologists involved in the treatment and management of cervical cancer. Obstetrician/gynecologists, nurses, physician assistants, fellows, residents, and other healthcare professionals with an interest in cervical cancer are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the rationale underlying the use of immunotherapy strategies for the management of cervical cancer
  • Assess emerging efficacy and safety data on immunotherapy, including application to evolving treatment paradigms for patients with locally advanced, unresectable, and metastatic forms of cervical cancer
  • Discuss evolving uses for biomarkers to practically inform clinical decision making concerning treatment strategies to manage cervical cancer
  • Apply practical case-based strategies across multidisciplinary teams to optimize outcomes in patients with cervical cancer in multiple lines of therapy

Faculty, Staff, and Planners’ Disclosures

Faculty

Bradley J. Monk
Bradley J. Monk, MD, FACS, FACOG
Professor, Division of Gynecologic Oncology
Arizona Oncology (The US Oncology Network)
University of Arizona College of Medicine–Phoenix
Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center
Medical Director, The US Oncology Research Network—Gynecologic Program
Phoenix, AZ

Disclosures: Consultant: AbbVie, Advaxis, Agenus, Amgen, Biodesix, Conjupro, Genmab, Gradalis, ImmunoGen, Immunomedics, Incyte, Mateon (formerly Oxigene), Merck, Myriad, Perthera, Pfizer, Precision Oncology, Puma, Samumed, Takeda, VBL; Speakers Bureau: AstraZeneca, Clovis, Janssen/ Johnson & Johnson, Roche/Genentech, Tesaro, Inc.

Robert L. Coleman
Robert L. Coleman, MD, FACOG, FACS
Professor and Executive Director, Cancer Network Research
Ann Rife Cox Chair in Gynecology
Department of Gynecologic Oncology and Reproductive Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Disclosures: Grant Research Support: AbbVie, AstraZeneca, Clovis, Genentech, Janssen, Merck; Consultant: AbbVie, Agenus, AstraZeneca, Clovis, GamaMabs, Genentech, Genmab, Janssen, Merck, Novocure, Tesaro.

Leslie M. Randall
Leslie M. Randall, MD, MAS
Associate Professor of Obstetrics and Gynecology
Director of Medical Education
Gynecologic Oncology Fellowship Director
Division of Gynecologic Oncology
University of California, Irvine
Irvine, CA

Disclosures: Leslie Randall, MD, MAS, has no relevant financial relationships with commercial interests to disclose.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest (COI).

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or any of the companies that provided commercial support for this program.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
2930
Filter By